Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Second Department of Neurology, "Attikon University Hospital", School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
J Neurointerv Surg. 2018 Jan;10(1):10-16. doi: 10.1136/neurintsurg-2016-012905. Epub 2017 Jan 31.
While mechanical thrombectomy (MT) has become the standard of care for patients with acute ischemic stroke (AIS) with emergent large-vessel occlusions (ELVO), recently published guidelines appropriately award top-tier evidence to the same selective criteria that were employed in completed clinical trials. We sought to evaluate the safety and effectiveness of MT in patients with AIS with ELVO who do not meet top-tier evidence criteria (TTEC).
We conducted an observational study on consecutive patients with AIS with ELVO who underwent MT at six high-volume endovascular centers. Standard safety outcomes (3-month mortality, symptomatic intracranial hemorrhage) and effectiveness outcomes (3-month functional independence: modified Rankin Scale scores of 0-2) were compared between patients meeting and failing TTEC.
The sample consisted of 349 (60%) controls fulfilling TTEC and 234 (40%) non-TTEC patients. Control patients meeting TTEC for MT tended to have higher functional independence rates at 3 months (47% vs 39%; p=0.055), while the rates of symptomatic intracerebral hemorrhage (sICH) were similar (9%) in both groups (p=0.983). In multivariable logistic regression models, adherence to TTEC for MT was not independently related to any safety outcome (sICH: OR 0.71, 95% CI 0.30 to 1.68, p=0.434; 3-month mortality: OR 1.27, 95% CI 0.69 to 2.33, p=0.448) or effectiveness outcome (3-month functional independence: OR 0.81, 95% CI 0.48 to 1.37, p=0.434; 3-month functional improvement: OR 0.73, 95% CI 0.48 to 1.11, p=0.138) after adjusting for potential confounders.
Approximately 40% of patients with AIS with ELVO offered MT do not fulfill TTEC for MT. Patients who did not meet TTEC had high rates of good clinical outcome and low complication rates.
虽然机械取栓(MT)已成为伴有紧急大血管闭塞(ELVO)的急性缺血性脑卒中(AIS)患者的标准治疗方法,但最近发布的指南恰当地将最高级别的证据授予了与已完成临床试验相同的选择性标准。我们旨在评估不符合最高级别证据标准(TTEC)的伴有 ELVO 的 AIS 患者接受 MT 的安全性和有效性。
我们对在六家高容量血管内治疗中心接受 MT 的伴有 ELVO 的 AIS 连续患者进行了一项观察性研究。在符合和不符合 TTEC 的患者之间比较了标准安全性结局(3 个月死亡率、症状性颅内出血)和有效性结局(3 个月功能独立性:改良 Rankin 量表评分 0-2)。
样本包括 349 名(60%)符合 TTEC 的对照组患者和 234 名(40%)不符合 TTEC 的患者。符合 TTEC 进行 MT 的对照组患者在 3 个月时更倾向于达到更高的功能独立性率(47% vs 39%;p=0.055),而两组的症状性颅内出血(sICH)发生率相似(9%;p=0.983)。在多变量逻辑回归模型中,MT 符合 TTEC 与任何安全性结局(sICH:OR 0.71,95%CI 0.30 至 1.68,p=0.434;3 个月死亡率:OR 1.27,95%CI 0.69 至 2.33,p=0.448)或有效性结局(3 个月功能独立性:OR 0.81,95%CI 0.48 至 1.37,p=0.434;3 个月功能改善:OR 0.73,95%CI 0.48 至 1.11,p=0.138)均无独立相关性,在调整潜在混杂因素后。
大约 40%的接受 MT 的伴有 ELVO 的 AIS 患者不符合 MT 的 TTEC。不符合 TTEC 的患者具有很高的良好临床结局和较低的并发症发生率。